Lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is a rare, progressive and systemic disease that typically results in cystic lung destruction. It predominantly affects women, especially during childbearing years. The term sporadic LAM is used for patients with LAM not associated with tuberous sclerosis complex (TSC), while TSC-LAM refers to LAM that is associated with TSC. The condition is often misdiagnosed as asthma or chronic obstructive pulmonary disease. The first pneumothorax precedes the diagnosis of LAM in 82% of patients. The consensus clinical definition of LAM includes multiple symptoms : Fatigue, Cough, Haemoptysis, Chest pain, Chylous complications arising from lymphatic obstruction.

  • Chylopericardium.
  • Angiomyolipomas
  • Lymphangioleiomyomatosis

Related Conference of Lymphangioleiomyomatosis

Lymphangioleiomyomatosis Conference Speakers